Ocular Surface Disease Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Completed
  • Ocular Surface Disease
  • +2 more
  • Bangkok, Thailand
    Faculty of medicine, Chulalongkorn university
2021-08-09
Aug 9, 2021
C
Recruiting
  • Ocular Surface Disease
  • Ocular Inflammation
  • CycloSPORINE Ophthalmic 0.1% Ophthalmic Emulsion
  • cationorm eye drops
  • Rome, Italy
    University Campus Bio Medico
2021-07-26
Jul 26, 2021
B
Withdrawn
  • Ocular Surface Disease
  • cyclosporine ophthalmic emulsion 0.05%
  • Needham, Massachusetts
    BostonSight
2021-07-20
Jul 20, 2021
K
Completed
  • Eye Diseases
  • +2 more
  • OSDI
  • +2 more
  • Kahramanmaraş, In The USA Or Canada, Please Select..., Turkey
    Abdullah Beyoğlu
2021-07-02
Jul 2, 2021
U
Recruiting
  • Glaucoma
  • Ocular Surface Disease
  • Xiidra (Lifitegrast ophthalmic solution) 5%
  • Fountain Valley, California
    Doheny Eye Center UCLA
2021-07-07
Jul 7, 2021
X
Recruiting
  • Hemodialysis
  • +3 more
  • ocular surface analyzer
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Jinan University
2021-07-01
Jul 1, 2021
S
Not yet recruiting
  • Ocular Surface Disease
  • Primary Open Angle Glaucoma
  • Tafluprost, timolol maleate
  • Taoyuan city, Taiwan
    Chang-Geng Medical Foundation Linkou Chang-Geng Memorial Hospita
2021-03-30
Mar 30, 2021
S
Enrolling by invitation
  • Dry Eye Syndromes
  • +5 more
  • Corneal Epithelial Stem Cell Transplant
  • Amarillo, Texas
    Rush Eye Associates
2021-03-08
Mar 8, 2021
B
Recruiting
  • Keratoconus
  • +8 more
  • Ocular surface optical coherence tomography
  • Needham, Massachusetts
    BostonSight
2021-01-26
Jan 26, 2021
J
Recruiting
  • Keratoconjunctivitis Sicca
  • +3 more
  • Questionnaires
  • +2 more
  • Baltimore, Maryland
    Wilmer Eye Insitute, Johns Hopkins School of Medicine
2021-01-14
Jan 14, 2021
A
Completed
  • Glaucoma
  • Ocular Surface Disease
  • Assessment of ocular surface staining (Oxford score 0-15 scale)
  • mean diurnal intraocular pressure-lowering
  • Thessaloniki, Greece
    University Department of Ophthalmology
2020-12-16
Dec 16, 2020
U
Completed
  • Dry Eye Syndromes
  • +2 more
  • Punctal plug
  • Oklahoma City, Oklahoma
    Dean McGee Eye Institute
2020-12-15
Dec 15, 2020
A
Completed
  • Glaucoma
  • Ocular Surface Disease
  • (no location specified)
2020-12-16
Dec 16, 2020
P
Not yet recruiting
  • Dry Eye Disease
  • +2 more
  • Dextenza 0.4Mg Ophthalmic Insert
  • (no location specified)
2020-12-10
Dec 10, 2020
U
Not yet recruiting
  • Ocular Surface Disease
  • Dry Eye Syndromes
  • Autologous platelet rich plasma eye drops
  • Toronto, Ontario, Canada
    Toronto Western Hospital
2020-10-22
Oct 22, 2020
S
Completed
  • Ocular Surface Disease
  • LK scleral lens
  • (no location specified)
2020-10-05
Oct 5, 2020
U
Completed
  • Ocular Surface Disease
  • Glaucoma
  • Hydrocortisone (CORTIVIS ®)
  • Campobasso, Italy
    University of Molise
2020-09-01
Sep 1, 2020
O
Completed
  • Graft Versus Host Disease
  • +7 more
  • Brimonidine Tartrate
  • Placebos
  • Phoenix, Arizona
  • +12 more
2020-06-30
Jun 30, 2020
V
Completed
  • Ocular Surface Disease
  • Glaucoma, Open-Angle
  • iStent or iStent inject implantation with concomitant cataract surgery
  • Sioux Falls, South Dakota
    Vance Thompson Vision
2020-06-28
Jun 28, 2020
U
Completed
  • Dry Eye Syndrome
  • Ocular Surface Disease
  • OSDI survey
  • Clermont-Ferrand, France
    CHU de Clermont-Ferrand
2020-04-23
Apr 23, 2020
B
Completed
  • Ocular Surface Disease
  • Omega 3
  • punctal plug
  • Abu Dhabi, United Arab Emirates
    ACDS
2019-11-24
Nov 24, 2019
N
Unknown status
  • Ocular Surface Disease
  • Premature
    • (no location specified)
    2019-08-23
    Aug 23, 2019
    N
    Unknown status
    • Ocular Surface Disease
    • Autologous blood applied to dry eye
    • East Kilbride, Lanarkshire, United Kingdom
      Hairmyres Hospital
    2019-08-19
    Aug 19, 2019